ask="4.12"
ask_size="5000"
average_daily_volume="183564"
bid="3.30"
bid_size="1000"
book_value="0.00"
change="+0.00"
change_from_200_day_moving_average="4.05"
change_from_50_day_moving_average="4.05"
change_from_52_week_high="-8.80"
change_From_52_week_low="0.29"
change_in_percent="+0.00%"
close="4.05"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.51"
ebitda="0.00"
eps_estimate_current_year="-1.08"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-1.17"
ex_dividend_date="N/A"
float_shares="N/A"
high="4.12"
high_52_weeks="12.85"
last_trade_date="12/30/2016"
last_trade_price="4.05"
last_trade_size="300"
last_trade_time="4:00pm"
low="3.85"
low_52_weeks="3.76"
market_capitalization="N/A"
moving_average_200_day="0.00"
moving_average_50_day="0.00"
name="Adaptimmune Therapeutics plc - "
notes="N/A"
one_year_target_price="15.20"
open="N/A"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+inf%"
percent_change_from_50_day_moving_average="+inf%"
percent_change_from_52_week_high="-68.48%"
percent_change_from_52_week_low="+7.71%"
previous_close="4.05"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="N/A"
short_ratio="0.00"
stock_exchange="NMS"
symbol="ADAP"
volume="145764"
weeks_range_52="3.76 - 12.85"
